Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Pharmacokinetic”

389 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 389 results

Early research (Phase 1)Study completedNCT05791565
What this trial is testing

Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants

Who this might be right for
Asthma
GlaxoSmithKline 28
Testing effectiveness (Phase 2)Study completedNCT01030575
What this trial is testing

Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)

Who this might be right for
Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+3 more
NICHD Neonatal Research Network 125
Testing effectiveness (Phase 2)Study completedNCT01417156
What this trial is testing

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 20
Early research (Phase 1)Not Yet RecruitingNCT07558200
What this trial is testing

Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsNon-Small Cell Lung CancerHepatocellular Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 138
Post-approval studies (Phase 4)Not Yet RecruitingNCT07633613
What this trial is testing

Pharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy.

Who this might be right for
Non-Small Cell Lung Carcinoma (NSCLC)Metastatic Head and Neck Squamous Cell Carcinoma
Centre Antoine Lacassagne 110
Early research (Phase 1)Study completedNCT04533048
What this trial is testing

A Clinical Study to Evaluate MW33 Injection

Who this might be right for
Covid19
Mabwell (Shanghai) Bioscience Co., Ltd. 42
Early research (Phase 1)Study completedNCT04576325
What this trial is testing

Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma

Who this might be right for
Asthma
TFF Pharmaceuticals, Inc. 17
Large-scale testing (Phase 3)Study completedNCT02797132
What this trial is testing

Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 62
Early research (Phase 1)Not Yet RecruitingNCT07014878
What this trial is testing

DCTY1102 Injection in Participants With Advanced Solid Tumors

Who this might be right for
Colorectal CancerLung CancerPancreatic Cancer
Beijing DCTY Biotech Co.,Ltd. 18
Post-approval studies (Phase 4)Study completedNCT01805284
What this trial is testing

Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia

Who this might be right for
Pneumonia
University Ghent 15
Early research (Phase 1)Looking for participantsNCT06773507
What this trial is testing

Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Esophageal CancersAdvanced Non-small Cell Lung Cancer (NSCLC)
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. 80
Early research (Phase 1)Study completedNCT00504439
What this trial is testing

Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 36
Early research (Phase 1)Study completedNCT05668897
What this trial is testing

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG171 Tablets

Who this might be right for
COVID-19
Fujian Akeylink Biotechnology Co., Ltd. 78
Early research (Phase 1)Study completedNCT02680561
What this trial is testing

A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma

Who this might be right for
Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02738801
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Lakefront Biotherapeutics NV 23
Early research (Phase 1)Ended earlyNCT02313012
What this trial is testing

Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors

Who this might be right for
Neoplasm Metastasis
Celgene 19
Early research (Phase 1)Not Yet RecruitingNCT06823245
What this trial is testing

Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Advanced Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 32
Early research (Phase 1)UnknownNCT05051930
What this trial is testing

A Clinical Trial of TQC3721 Suspension for Inhalation

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 114
Testing effectiveness (Phase 2)Study completedNCT04573322
What this trial is testing

Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects

Who this might be right for
SARS-CoV-2 (Covid19)
Diffusion Pharmaceuticals Inc 25
Testing effectiveness (Phase 2)WithdrawnNCT03385395
What this trial is testing

Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Octapharma
Next Page